Italian Journal of Medicine,
Journal Year:
2024,
Volume and Issue:
18(4)
Published: Oct. 29, 2024
The
objective
of
this
study
was
to
investigate
the
mental
disturbances
among
COVID-19
survivors
while
also
examining
their
quality
life.
A
retrospective
cohort
conducted
in
northern
Vietnam.
Anxiety,
depression,
insomnia,
cognitive
impairment,
and
life
were
assessed
using
Patient
Health
Questionnaire-9,
Generalized
Anxiety
Disorder-7,
Pittsburgh
Sleep
Quality
Index,
Mini-Cog,
Short
Form-8
(SF-8),
respectively.
Information
regarding
COVID
post-COVID
conditions
retrospectively
collected
through
direct
interviews.
Ordinal
logistic
regression
employed
identify
factors
associated
with
severity
depression
anxiety;
binary
used
presence
sleep
disturbance
linear
utilized
physical
components
SF-8.
total
1596
participants
included
study,
prevalence
anxiety,
disturbance,
impairment
being
8.7%,
16.9%,
23.4%,
5.6%,
Experiencing
discrimination
during
infection
syndrome
both
linked
long-term
outcomes
insomnia
related
a
decline
Our
provided
initial
insights
into
over
an
extended
period,
stigmatization
identified
as
primary
factors.
longitudinal
random
sampling,
control
group,
measures
better
recall
bias
is
recommended.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(1), P. 97 - 97
Published: Jan. 16, 2024
Long
COVID
is
a
recently
described
entity
that
responsible
for
significant
morbidity
and
has
consequences
ranging
from
mild
to
life-threatening.
The
underlying
mechanisms
are
not
completely
understood,
treatment
options
currently
limited,
as
existing
data
focus
more
on
risk
factors
predictors.
Smoking
been
reported
factor
poor
outcomes
of
acute
SARS-CoV-2
infection
seems
also
play
role
in
mediating
post-COVID-19
symptoms.
We
aimed
review
relevant
work
addressing
the
interaction
between
smoking
long
order
characterize
smoking’s
possibly
identify
new
research
directions.
Methods:
PubMed/MEDLINE
database
was
searched
using
keywords
‘smoking’,
‘long
COVID’,
‘post-acute
COVID’
English-language
articles
published
up
October
2023.
Results
conclusions:
From
374
initial
hits,
total
36
papers
were
deemed
aim
review.
There
variability
concerning
ways
which
tobacco
usage
quantified
reported;
still,
there
compelling
evidence
linking
an
increased
developing
manifestations
post-acute-COVID
disease.
Some
clinical
conditions,
such
dyspnea,
cardiovascular
symptoms,
cognitive
or
mental-health
impairment,
seem
be
relatively
strongly
associated
with
smoking,
while
connection
upper-airway
involvement
less
certain.
available
support
recommending
cessation
tool
prevention
COVID.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
11
Published: Jan. 22, 2024
Background
Robust
data
comparing
long
COVID
in
hospitalized
and
non-hospitalized
patients
middle-income
countries
are
limited.
Methods
A
retrospective
cohort
study
was
conducted
Brazil,
including
patients.
Long
diagnosed
at
90-day
follow-up
using
WHO
criteria.
Demographic
clinical
information,
the
depression
screening
scale
(PHQ-2)
day
30,
compared
between
groups.
If
PHQ-2
score
is
3
or
greater,
major
depressive
disorder
likely.
Logistic
regression
analysis
identified
predictors
protective
factors
for
COVID.
Results
total
of
291
1,118
with
COVID-19
were
included.
The
prevalence
47.1%
49.5%,
respectively.
Multivariable
logistic
showed
female
sex
(odds
ratio
[OR]
=
4.50,
95%
confidence
interval
(CI)
2.51–8.37),
hypertension
(OR
2.90,
CI
1.52–5.69),
>
6.50,
1.68–33.4)
corticosteroid
use
during
hospital
stay
2.43,
1.20–5.04)
as
patients,
while
2.52,
1.95–3.27)
3.88,
2.52–6.16)
Conclusion
prevalent
both
Positive
30
post-infection
can
predict
Early
helps
health
staff
to
identify
a
higher
risk
COVID,
allowing
an
early
diagnosis
condition.
Frontiers in Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: Aug. 24, 2023
Introduction
Few
studies
have
evaluated
the
presence
of
Post
COVID-19
conditions
(PCC)
in
people
from
Latin
America,
a
region
that
has
been
heavily
afflicted
by
pandemic.
In
this
study,
we
describe
frequency,
co-occurrence,
predictors,
and
duration
23
symptoms
cohort
Mexican
patients
with
PCC.
Methods
We
prospectively
enrolled
followed
adult
hospitalized
for
severe
at
tertiary
care
centre
Mexico
City.
The
incidence
PCC
was
determined
using
questionnaires.
Unsupervised
clustering
symptom
co-occurrence
Kaplan–Meier
analyses
persistence
were
performed.
effect
baseline
clinical
characteristics
Cox
regression
models
reported
hazard
ratios
(HR).
Results
found
amongst
192
PCC,
respiratory
problems
most
prevalent
commonly
co-occurred
functional
activity
impairment.
56%
had
≥5
persistent
symptoms.
Symptom
probability
360
days
0.78.
Prior
SARS-CoV-2
vaccination
infection
during
Delta
variant
wave
associated
shorter
Male
sex
impairment
Hypertension
diabetes
longer
Previous
accelerated
recovery.
Discussion
our
cohort,
frequent
(particularly
neurocognitive
ones)
persistent.
Importantly,
prior
resulted
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0312351 - e0312351
Published: Jan. 28, 2025
Background
While
mental
health
alterations
during
active
COVID-19
infection
have
been
documented,
the
prevalence
of
long-term
consequences
remains
unclear.
This
study
aimed
to
determine
symptoms—depression,
anxiety,
stress,
and
suicidal
tendencies—and
identify
their
trends
associated
risk
factors
in
individuals
with
long-COVID.
Methods
We
conducted
a
systematic
literature
search
databases
including
PubMed,
EMBASE,
Scopus,
CINAHL,
Cochrane
Library,
Web
Science,
PsycINFO
up
August
2024,
targeting
observational
studies
published
English.
Study
quality
was
assessed
using
structured
standard
tools.
The
primary
outcome
pooled
depression,
tendencies
Secondary
outcomes
included
these
problems
over
time
identification
determinants.
Results
A
total
94
eligible
were
analysis.
estimates,
regardless
follow
times
duration,
as
follows:
25%
(95%CI:22–28%;
PI:1–59%);
anxiety
(adjusted
via
trim
fill
method),
23%(95%CI:21–25%;PI:2–35%);
composite
depression
and/or
(95%CI:23–27%;PI:2–51%);
26%(95%CI:13–39%;PI:1–69%);
suicidality,
19%(95%CI:15–22%;PI:13–25%).
results
meta-regression
analyses
revealed
statistically
significant
trend
showing
gradual
decrease
(RD
=
-0.004,P
0.022).
Meta-regression
indicated
that
being
female
younger
age
significantly
higher
symptoms.
design
setting
did
not
contribute
heterogeneity.
Conclusion
One-fourth
individual
long-COVID
experience
symptoms,
which
remain
prevalent
even
two
years
post-infection
despite
slight
decreasing
trend.
Factors
such
gender
linked
rates
depression.
These
findings
indicate
need
for
ongoing
screening
early
interventions
mitigate
psychological
distress
patients.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1256 - 1256
Published: Aug. 5, 2024
COVID-19
is
still
a
major
public
health
concern,
mainly
due
to
the
persistence
of
symptoms
or
appearance
new
symptoms.
To
date,
more
than
200
long
COVID
(LC)
have
been
described.
The
present
review
describes
and
maps
its
relevant
clinical
characteristics,
pathophysiology,
epidemiology,
genetic
nongenetic
risk
factors.
Given
currently
available
evidence
on
LC,
we
demonstrate
that
there
are
gaps
controversies
in
diagnosis,
detection
prognostic
predictive
factors,
as
well
role
viral
strain
vaccination.
Frontiers in Psychology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 30, 2024
Purpose
This
study
aimed
to
assess
the
association
of
anxiety,
headache,
and
insomnia
on
QoL
patients
with
long
COVID-19.
Methods
We
conducted
a
cross-sectional
survey
between
August
2020
March
2023.
A
total
200
participants
were
eligible,
53
excluded
147
COVID
included.
was
evaluated
across
eight
domains
using
36-Item
Short
Form
Health
Survey
(SF-36).
Standardized
protocols
including
Beck
Anxiety
Inventory
(BAI)
(
n
=
103),
Pittsburgh
Sleep
Quality
Index
(PSQI)
73),
Migraine
Disability
Assessment
(MIDAS)
67)
also
used.
Results
Participants
sleep
disorders
had
significantly
lower
Vitality
p
<
0.001).
anxiety
0.001),
poorer
Mental
0.008),
more
severe
Bodily
Pain
0.008).
headache
0.032),
0.036),
Physical
Functioning
0.016).
both
0.005)
0.043)
domain
scores.
Correlation
analysis
revealed
that
higher
scores
for
disorder,
independently
correlated
various
domains.
The
presence
disorder
associated
fourfold
increase
in
risk
experiencing
diminished
(odds
ratio
[OR]4.47;
95%
CI
1.01–19.69;
0.048).
Conclusion
sleep,
tended
have
worse
QoL.
most
adversely
affected
COVID.
poor
Vitality.
JMIR Research Protocols,
Journal Year:
2024,
Volume and Issue:
13, P. e52643 - e52643
Published: Aug. 13, 2024
Background
Immunocompromised
individuals
are
known
to
respond
inadequately
SARS-CoV-2
vaccines,
placing
them
at
high
risk
of
severe
or
fatal
COVID-19.
Thus,
immunocompromised
and
their
caregivers
may
still
practice
varying
degrees
social
physical
distancing
avoid
However,
the
association
between
COVID-19
quality
life
has
not
been
comprehensively
evaluated
in
any
study.
Objective
We
aim
measure
behaviors
among
those
person-centric
outcomes,
including
health-related
(HRQoL)
measures,
health
state
utilities,
anxiety
depression,
work
school
productivity
impairment.
Methods
A
patient-informed
protocol
was
developed
conduct
EAGLE
Study,
a
large
cross-sectional,
observational
study,
this
paper
describes
that
protocol.
is
designed
outcomes
individuals,
children
(aged
≥6
mo)
caregivers,
nonimmunocompromised
adults
United
States
Kingdom
who
report
no
receipt
passive
immunization
against
previously
novel
self-
observer-reported
instrument,
Physical
Distancing
Scale
for
Avoidance
(PDS-C19),
behavior
levels
cross-sectionally
retrospectively.
Using
an
interim
randomly
selected
subset
study
population,
PDS-C19
psychometric
properties
will
be
assessed,
structural
validity,
internal
consistency,
known-group
convergent
validity.
Associations
(correlations)
assessed
validated
HRQoL-related
measures
utilities.
Structural
equation
modeling
regression
used
assess
these
associations,
adjusting
potential
confounders.
Participant
recruitment
data
collection
took
place
from
December
2022
June
2023
using
direct-to-patient
channels,
panels,
clinician
referral,
patient
advocacy
groups,
media,
with
immunocompromising
diagnosis
confirmation
collected
25%
participants.
The
planned
total
sample
size
3718
participants
participant-caregiver
pairs.
Results
reported
by
status,
condition
category,
country,
age
group,
other
subgroups.
All
analyses
reporting
were
completed
2023.
submitted
publication
peer-reviewed
journals
2024-2025.
Conclusions
This
quantify
individuals’
HRQoL
as
well
International
Registered
Report
Identifier
(IRRID)
RR1-10.2196/52643
American journal of clinical and experimental immunology.,
Journal Year:
2024,
Volume and Issue:
13(4), P. 142 - 164
Published: Jan. 1, 2024
As
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
continues
to
evolve,
mortality
rates
of
disease
2019
(COVID-19)
have
significantly
decreased.
However,
a
variable
proportion
patients
exhibit
persistent
prolonged
symptoms
COVID-19
infection
(long
COVID).
This
virus
primarily
attacks
system,
but
numerous
individuals
complain
skeletal
muscle
pain
or
worsening
pre-existing
post
COVID-19,
which
severely
affects
the
quality
life
and
recovery.
Currently,
there
is
limited
research
on
in
long
COVID.
In
this
brief
review,
we
review
potential
pathological
mechanisms
COVID,
summarize
various
auxiliary
examinations
treatments
for
We
consider
abnormal
activation
inflammatory
response,
myopathy,
neurological
damages
as
pivotal
A
comprehensive
examination
important
order
work
out
effective
treatment
plans
relieve
pain.
So
far,
rehabilitation
interventions
myalgia
COVID
contain
are
not
drug,
nutraceutical
therapy,
gut
microbiome-targeted
interventional
therapy
strength
training.
Our
study
provides
mechanism
reference
clinical
researches,
highlighting
importance
approach
management
The
relief
will
accelerate
process,
improve
activities
daily
living
enhance
life,
promoting
return
society
with
profound
significance.